This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Whiteman, D. C. Articles by Green, A. C. Search for Related Content PubMed PubMed Citation Articles by Whiteman, D. C. Articles by Green, A. C.

Anatomic Site, Sun Exposure, and Risk of Cutaneous Melanoma

David C. Whiteman, Mark Stickley, Peter Watt, Maria Celia Hughes, Marcia B. Davis, Adèle C. Green

From the Queensland Institute of Medical Research, Brisbane, Australia

Address reprint requests to David C. Whiteman, MBBS, PhD, Division of Population Studies and Human Genetics, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Queensland 4029 Australia; e-mail: david.whiteman{at}qimr.edu.au

PURPOSE: Sunlight is the principal environmental risk factor for cutaneous melanoma. A current hypothesis postulates that the role of sunlight in causing melanoma differs according to anatomic site. We tested this hypothesis in a population-based case-case comparative study of melanoma patients.

METHODS: Patients were sampled from the Queensland cancer registry in three groups: superficial spreading or nodular melanomas of the trunk (n = 154), of the head and neck (HN; n = 76), and lentigo maligna (LM) and lentigo maligna melanoma (LMM; for both LM and LMM, n = 76). Data were collected on school-age sun exposure and occupational and recreational sun exposure in adulthood. Odds ratios (OR) and 95% CIs were calculated using polytomous logistic regression.

RESULTS: HN melanoma patients were substantially more likely than trunk patients to have higher levels of sun exposure in adulthood (OR, 2.43; 95% CI, 0.98 to 5.99) and specifically, higher levels of occupational exposure (OR, 3.25; 95% CI, 1.32 to 8.00), but lower levels of recreational sun exposure (OR, 0.50; 95% CI, 0.21 to 1.19). LM and LMM patients reported higher occupational exposure and lower recreational sun exposure than trunk melanoma patients, although this was not significant. We found no significant differences between the groups for school-age sun exposures.

CONCLUSION: Melanomas developing at different body sites are associated with distinct patterns of sun exposure. Melanomas of the head and neck are associated with chronic patterns of sun exposure whereas trunk melanomas are associated with intermittent patterns of sun exposure, supporting the hypothesis that melanomas may arise through divergent causal pathways.

Supported by grants from the Queensland Cancer Fund and the National Cancer Institute (CA 88363-01A1). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.

Presented in part during an invited plenary session at the 6th World Congress on Melanoma, Vancouver, British Columbia, Canada, September 8, 2005 (D.C.W.).

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

This article has been cited by other articles:

				S. W Menzies Is sun exposure a major cause of melanoma? Yes BMJ, July 22, 2008; 337(jul22_2): a763 - a763. [Full Text]

				M. A. Tucker Is Sunlight Important to Melanoma Causation? Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 467 - 468. [Full Text] [PDF]

				A. C. Green and G. M. Williams Point: Sunscreen Use Is a Safe and Effective Approach to Skin Cancer Prevention Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1921 - 1922. [Full Text] [PDF]

				N. E. Thomas, S. N. Edmiston, A. Alexander, R. C. Millikan, P. A. Groben, H. Hao, D. Tolbert, M. Berwick, K. Busam, C. B. Begg, et al. Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 991 - 997. [Abstract] [Full Text] [PDF]

				R. F. Ozols, R. S. Herbst, Y. L. Colson, J. Gralow, J. Bonner, W. J. Curran Jr, B. L. Eisenberg, P. A. Ganz, B. S. Kramer, M. G. Kris, et al. Clinical Cancer Advances 2006: Major Research Advances in Cancer Treatment, Prevention, and Screening--A Report From the American Society of Clinical Oncology J. Clin. Oncol., January 1, 2007; 25(1): 146 - 162. [Abstract] [Full Text] [PDF]